• Caspofungin: β-Glucan Inhibition in Candida Research

  2026-08-07

  Caspofungin is a lipopeptide antifungal drug that inhibits β-1,3-glucan synthase and weakens the fungal cell wall. Supplier-reported potency data and a cited murine Candida auris study support its use as a mechanistic comparator in antifungal therapeutics research.

• Shared Specificities of Inflammatory and Apoptotic Caspases

  2026-08-07

  This study introduces a tetrapeptide tool derived from the IL-18 sequence to probe substrate selectivity among human inflammatory and apoptotic initiator caspases. The findings reveal unexpected overlap in inhibitor and substrate specificity, including that VX-765, typically a caspase-1 inhibitor, also inhibits caspase-8, refining how researchers interpret caspase inhibition in inflammatory and cell death pathways.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-08-06

  The referenced study uncovers how HOXC8, a transcription factor, restricts pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression through HDAC1/2 recruitment. These findings clarify a non-canonical regulatory axis in tumor cell survival, suggesting new avenues for inflammation research and targeted apoptosis assays.

• Ibrexafungerp and Caspofungin: Tackling Drug-Resistant C. au

  2026-08-06

  Wiederhold et al. provide crucial evidence that ibrexafungerp, a novel triterpenoid antifungal, and caspofungin, a lipopeptide antifungal drug, are effective against fluconazole-resistant Candida auris in both in vitro and in vivo models. Their findings highlight the value of β-(1,3)-D-glucan biosynthesis inhibition for overcoming multidrug-resistant Candida infections, informing antifungal agent development and protocol design.

• Z-YVAD-FMK Caspase-1 Inhibitor: Workflows and Troubleshootin

  2026-08-05

  Z-YVAD-FMK enables targeted dissection of pyroptosis and inflammasome pathways with high selectivity for caspase-1, proven in cancer and inflammation research. This guide translates new mechanistic insights into practical protocols and troubleshooting strategies, including lessons from recent HOXC8 studies.

• IgSF6 Deficiency Boosts Intestinal Macrophage Antibacterial

  2026-08-05

  This study identifies IgSF6, an ER-localized immunoglobulin superfamily member, as a key regulator of endoplasmic reticulum stress and inflammation in intestinal macrophages. IgSF6 deficiency enhances macrophage bactericidal function during infection by amplifying ER stress signaling and inflammatory pathways, revealing new dimensions in gut immune regulation.

• HyperScript RT SuperMix for qPCR: Precision cDNA Synthesis

  2026-08-04

  HyperScript RT SuperMix for qPCR enables high-fidelity cDNA synthesis from complex and low-abundance RNA templates. Its engineered reverse transcriptase and optimized primer blend support robust gene expression analysis, particularly in challenging two-step qRT-PCR workflows. This kit maximizes reproducibility and sensitivity while simplifying protocol steps.

• Z-YVAD-FMK: Selective Caspase-1 Inhibitor for Pyroptosis Res

  2026-08-04

  Z-YVAD-FMK is a potent, irreversible caspase-1 inhibitor widely used to dissect inflammasome-driven signaling and pyroptosis. Its cell-permeable and selective nature enables robust suppression of caspase-1-dependent IL-1β release and cell death in both in vitro and in vivo models, supporting advanced apoptosis and cancer research.

• Cyclic di-GMP: Applied Workflows for Biofilm & Immune Studie

  2026-08-03

  Cyclic di-GMP empowers researchers to dissect bacterial biofilm dynamics and modulate innate immunity through precise, reproducible workflows. This article bridges novel antitoxin mechanisms with actionable protocol tips and troubleshooting, enabling advanced cancer immunotherapy and persistent infection studies.

• HOXC8 Regulates Pyroptosis in NSCLC via Caspase-1 Suppressio

  2026-08-03

  This study reveals that HOXC8 suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 transcription. The findings clarify a previously unexplored epigenetic link between homeobox gene regulation and inflammasome-mediated cell death, suggesting new approaches for inflammation and cancer research.

• Ricin-Induced Necroptosis in Lung Epithelial Cells: Mechanis

  2026-08-02

  The referenced study uncovers how ricin toxin, combined with bystander macrophage-derived factors, triggers necroptosis in lung epithelial cells. These findings clarify the cellular interactions and signaling events underpinning lung injury during ricin toxicosis, with implications for inflammasome and cell death pathway research.

• ZNF263 Drives STAT3-Mediated Chemoradiotherapy Resistance in

  2026-08-01

  This study uncovers how zinc finger protein 263 (ZNF263) directly activates STAT3, promoting proliferation, invasion, and chemoradiotherapy resistance in colorectal cancer (CRC) cells. By elucidating the ZNF263–STAT3 regulatory axis, the paper provides a new mechanistic basis for targeting therapy resistance in CRC.

• X-Gal in Molecular Cloning: Precision, Mechanism, and Next-G

  2026-07-31

  Explore the advanced mechanism of X-Gal in blue-white colony screening, its biochemical precision, and how recent olfactory receptor research informs assay optimization. Gain unique insights into β-galactosidase assay design and practical protocol parameters.

• Caspofungin for Antifungal Assays: Reproducibility and Proto

  2026-07-31

  This scenario-driven article addresses practical laboratory challenges in antifungal research, focusing on the use of Caspofungin (SKU B4972) as a high-reliability lipopeptide antifungal drug. Learn how protocol design, assay optimization, and evidence-based vendor selection converge to ensure reproducible results for azole-resistant Candida studies.

• VX-765: Potent Caspase-1 Inhibitor for Pyroptosis Research

  2026-07-30

  VX-765 is a potent and selective, orally bioavailable caspase-1 inhibitor that enables precise suppression of IL-1β and IL-18 maturation, facilitating targeted studies of inflammasome-driven inflammation and pyroptosis. The active metabolite, VRT-043198, exhibits high selectivity for caspase-1 and is widely used in preclinical models of rheumatoid arthritis and HIV-associated CD4 T-cell loss. APExBIO provides validated, high-purity VX-765 (SKU A8238) for advanced inflammation research.

11648 records 1/777 page Next 12345 下5页 Last page